| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Active Research
Forum: Mapping Cancer Markers Forum
Thread: Interesting News Articles About Cancer |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 530
|
|
| Author |
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges: 
|
Learn more about Genetics & Genomics on National DNA Day, April 25
National DNA Day is the perfect time to share what you know about DNA and learn more. Visit the National DNA Day website to find resources for teachers, students, and anyone else who wants to improve their understanding of DNA, genetics, and genomics. The website also has information for experts in genetics and genomics who are interested in outreach to schools and other places in their community. Read more about how you can participate in National DNA Day. https://www.cdc.gov/features/dnaday/index.html  |
||
|
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges:
|
Success in first phase of human trials for colorectal cancer vaccine
The new vaccine treatment is designed to stimulate a patient's immune system to attack and destroy the cancer. [. . .] The big breakthrough that inspired this specific vaccine was the discovery that almost all colorectal cancers seem to express a molecule called GUCY2C. This particular molecule is also found naturally in intestinal epithelial cells, however, its compartmentalized presence in those cells means any vaccine that targets it should only direct immune cells to tumors and not healthy intestinal tissue. [. . .] The GUCY2C molecule is also expressed by gastric, esophageal and pancreatic cancers, meaning this prospective vaccine could be useful in targeting a large number of common cancers. More at: https://newatlas.com/colon-cancer-vaccine-human-trial-results/59432/ |
||
|
|
[VENETO] boboviz
Senior Cruncher Joined: Aug 17, 2008 Post Count: 183 Status: Offline Project Badges: 
|
|
||
|
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges:
|
Existing drug that offers metastatic cell dormancy over death may be better for combating cancer
Current cancer drugs tend to target primary tumors because they're made to focus in on cells that are growing faster than normal cells. But that means they miss the metastatic cells that may be circulating through a patient's body, which can lie inactive for years at a time. Rather than find a way to kill these rogue traveling cancer cells, the new study investigated how to keep them in that inactive state. In tests on mice with breast cancer, the team found that a drug called fostamatinib can do the trick. The drug, already approved for use in humans, inhibits a protein called spleen tyrosine kinase (SYK), which is found in these metastatic cells. more at: https://newatlas.com/cancer-metastasis-dormant-drug/59459/ |
||
|
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges:
|
Biological barrier could keep cancer from metastasizing
Researchers at EPFL, the University of Bern and the Swiss Institute of Bioinformatics have discovered a particular protein signaling pathway that controls whether a tumor can spread or not, making it a good target for future drugs. The research focused on a cell receptor called ALK7, studying its role in mice with breast cancer or pancreatic neuroendocrine tumors. The team discovered that when activated by the protein activin B, ALK7 triggers a signaling pathway that can kill cancer cells through the process of apoptosis, as well as suppressing metastasis, and preventing new tumors from forming (tumoriogensis). [. . . ] Higher levels of ALK7 expression in human cancer patients seemed to line up with periods of remission. In other cases, higher levels were found to keep breast cancer metastasis at bay for longer. Some studies even go as far to suggest that blocking metastasis is more important than killing cancer itself. More at: https://newatlas.com/cancer-metastasis-pathway-alk7/59567/ |
||
|
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges:
|
Scorpion venom is helping surgeons detect brain cancer
The new imaging technique is based around a novel compound called tozuleristide (BLZ-100, which is an optimized synthetic version of a peptide found in scorpion venom. The compound naturally binds to [glioma] brain cancer cells, and researchers added a fluorescent dye so under near-infrared light the tumor cells become easily distinguishable from normal tissue. "With this fluorescence, you see the tumor so much clearer because it lights up like a Christmas tree," explains Adam Mamelak, senior author on the new research. More at: https://newatlas.com/scorpion-venom-brain-cancer-tumor-imaging-trial/59622/ |
||
|
|
QuantumEthos
Senior Cruncher Joined: Jul 2, 2011 Post Count: 336 Status: Offline Project Badges: 
|
Watson successfully diagnoses treatments for VA
----------------------------------------We need Watson to examine and aid our research goals & data ... Watson is available on IBM Cloud and would be usable by all projects on all data privately and collectively. "IBM Helping the future by helping now" right now Regards RS https://cloud.ibm.com/catalog https://cloud.ibm.com/catalog/services/watson-openscale https://cloud.ibm.com/catalog/services/watson-studio https://cloud.ibm.com/catalog/services/watson-assistant https://cloud.ibm.com/catalog/services/powerai https://cloud.ibm.com/catalog/infrastructure/virtual-server-group https://www.youtube.com/watch?v=ac58J3PWcrQ https://www.youtube.com/watch?v=ZPXCF5e1_HI "Transient Virtual Server DocsTerms If you have flexible workloads and need cost savings, Transient Virtual Servers may be a good option. Transient instances are provisioned when there is unused capacity available in IBM Cloud - therefore, when resources are required for full-paying instances, you can also lose these Transient instances" **** Research topics Bring back a combination of the united works on cancer of the various DNA projects and also the ability Fighting cancer has of using the GPU. Unite HPC once again in a merging and cross validation of data that is irrespective of age versus illness type. Combine case data with validation for the Cancer markers project and re invent improved validation for associated works of the WCG HPC Class Science exploration unit and Boinc Berkley General class genetic exploration units such as rosetta & or general community at large https://www.worldcommunitygrid.org/research/scc1/details.do https://www.worldcommunitygrid.org/research/hcc1/overview.do https://www.worldcommunitygrid.org/research/hdc/overview.do https://www.worldcommunitygrid.org/research/mcm1/details.do Well how will this help ? aditional samples for the Xray crystal examiner ML Code, Crosscheck DNA markers against valid samples of active or cured cancers .. Further Examine the Data though markers and back will allow plausible additional markers & validate plausible causes for original cancer & childhood cancer data. Regards RS [Edit 1 times, last edit by QuantumEthos at May 14, 2019 7:48:54 PM] |
|||
|
||||
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges:
|
Google's AI for lung cancer diagnosis proves more accurate than radiologists in early trial
In Google's case, it trained its machine learning algorithm on more than 45,000 chest CT scans, taken from the National Health Institute and Northwestern University, some of which featured cancer in various stages. The algorithm works by generating a 3D model from the CT scan, using that to detect tiny malignant tissue in the lung nodules that would otherwise be difficult to spot and produce an overall lung cancer malignancy prediction. The algorithm was then put to work using a single CT scan for diagnosis, with the accuracy of the algorithm compared to that of six board-certified radiologists. Google says it detected five percent more cancer cases and reduced false-positives by more than 11 percent. Much more at: https://newatlas.com/google-ai-lung-cancer-diagnosis/59761/ |
||
|
|
alged
Master Cruncher FRANCE Joined: Jun 12, 2009 Post Count: 2358 Status: Offline Project Badges:
|
New in the detection of bladder carcinomas. A specific and effective urine test could identify these tumors.
----------------------------------------Called UroMuTERT, a urine test proves its effectiveness in the diagnosis of urothelial carcinoma, cancers of the bladder and the upper urinary tract. It consists in identifying two recurrent mutations in this type of tumor associated with the telomerase reverse transcriptase (TERT) gene. These can be observed in cells present in the urine but in small quantities. This is why the test is particularly sensitive. A non-invasive test To validate its effectiveness, the team of Dr. Florence Le Calvez-Kelm of the International Agency for Research on Cancer (IARC) evaluated 93 patients diagnosed and 94 control participants in France, as well as 50 patients and 50 controls in Portugal . Results, "the test was very sensitive and specific to the detection of all forms of urothelial cancers," says the researcher. He even managed to identify low-grade and early forms. "This test could significantly improve the screening of these cancers and avoid many unnecessary invasive procedures such as cyctoscopy," she says. Indeed, until now, to detect these cancers, the protocol is based on these invasive and expensive examinations, associated with a urinary cytology. The latter does not identify tumors early. * cystoscopy consists in exploring the internal walls of the bladder thanks to a thin tube provided at its end with a lens connected to a light source Source: IARC WHO Lyon, 20 May 2019 above is a Google translation from french article in the newsletter Destination Santé   |
||
|
|
Glen David Short
Senior Cruncher Joined: Nov 6, 2008 Post Count: 185 Status: Offline Project Badges: 
|
----------------------------------------  |
||
|
|
|